Published in Lancet on October 31, 1981
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions. Proc Natl Acad Sci U S A (1993) 3.48
Management of adult acute myelogenous leukaemia. Br Med J (1973) 3.33
Foetal thymic transplant in a case of Digeorge's syndrome. Lancet (1968) 2.85
Immunotherapy for acute myelogenous leukaemia. Br J Cancer (1973) 2.67
Infectious complications of subcutaneous interleukin-2 and interferon-alpha. Lancet (1992) 2.65
Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J (1971) 2.50
Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet (1979) 2.48
Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome). Lancet (1968) 2.40
High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet (1983) 2.33
Five-year analysis of protective isolation. Lancet (1971) 2.31
Detection of micrometastases in patients with primary breast cancer. Lancet (1983) 2.07
The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet (1980) 2.03
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
Encephalopathy in acute leukaemia associated with methotrexate therapy. Arch Dis Child (1972) 1.93
The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol (1996) 1.89
Hemolytic anemia in Wilson's disease. N Engl J Med (1967) 1.78
Localization and differential expression of two isoforms of the tight junction protein ZO-1. Am J Physiol (1992) 1.72
Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet (1977) 1.69
The surrogate light chain in B-cell development. Immunol Today (1993) 1.64
Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. Br Med J (1973) 1.50
Myelopathy after intrathecal chemotherapy. A case report with unique magnetic resonance imaging changes. Cancer (1994) 1.49
Outcome of biphenotypic acute leukemia. Haematologica (1999) 1.46
Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia. Bone Marrow Transplant (1999) 1.45
Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Br J Cancer (1977) 1.43
Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia. Hosp Med (1998) 1.42
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med (1986) 1.42
The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms. J Urol (1997) 1.40
Problems of infection after bone marrow transplantation. J Clin Pathol (1983) 1.40
L-asparaginase in treatment of acute leukaemia and lymphosarcoma. Br Med J (1970) 1.39
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer (1981) 1.39
Tumour lysis syndrome, case report and review of the literature. Ann Oncol (1996) 1.39
Serial study of T lymphocytes in childhood leukemia during remission. Pediatr Hematol Oncol (1993) 1.39
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36
Recovery of human foetal liver cells after storage in liquid nitrogen. J Clin Pathol (1968) 1.34
Risk factors for acute graft-versus-host disease. Br J Haematol (1987) 1.33
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet (1983) 1.31
Hepatic coma due to acute hepatic necrosis treated by exchange blood-transfusion. Lancet (1967) 1.30
Pneumocystis carinii pneumonitis: a serological study. J Clin Pathol (1979) 1.30
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet (1994) 1.29
Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet (1971) 1.26
Conception and congenital abnormalities after chemotherapy of acute myelogenous leukaemia in two men. Br Med J (1976) 1.26
Further observations on patients with a chromosomal abnormality associated with polycythaemia vera. Br J Haematol (1968) 1.18
Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J R Soc Med (1983) 1.17
Hereditary lymphopenic agammaglobulinemia associated with a distinctive form of short-limbed dwarfism and ectodermal dysplasia. J Pediatr (1969) 1.17
Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J (1974) 1.15
Response of human foetal thymocytes to phytohaemagglutinin (PHA). Immunology (1970) 1.14
Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia. Br J Haematol (1997) 1.14
Mianserin and blood dyscrasias. Br J Clin Pharmacol (1983) 1.14
PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients. J Clin Pathol (1998) 1.13
Changes in serum amylase and its isoenzymes after whole body irradiation. Br Med J (Clin Res Ed) (1982) 1.13
A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant (2006) 1.12
Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol (1987) 1.11
Granulocytic sarcoma: a diagnosis to be considered in unusual lymphoma syndromes. Postgrad Med J (1987) 1.10
Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol (2000) 1.10
Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapy. Br J Haematol (1976) 1.10
Pneumococcal infection in a mother and infant. Lancet (1984) 1.10
Cytologic diagnosis of cryptococcal meningitis. N Engl J Med (1972) 1.09
Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus. Lancet (1970) 1.08
HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy. Transplantation (1975) 1.08
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood (1993) 1.08
Viridans streptococcal bacteraemia in patients with haematological and solid malignancies. Eur J Cancer (1991) 1.08
Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. Bone Marrow Transplant (1988) 1.07
A novel candidate oncogene, MCT-1, is involved in cell cycle progression. Cancer Res (1998) 1.06
Some properties of cryopreserved acute leukemia cells. Cryobiology (1973) 1.05
Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.05
Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival. Leuk Lymphoma (2000) 1.05
Immunological restitution in lymphopenic immunological deficiency syndrome. Lancet (1968) 1.05
VAD chemotherapy as remission induction for multiple myeloma. Br J Cancer (1995) 1.04
Thymic alymphoplasia with XX-XY lymphoid chimerism secondary to probable maternal-fetal transfusion. J Pediatr (1969) 1.03
Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B. Antimicrob Agents Chemother (1992) 1.03
Analysis of treatment of childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiation. Br J Cancer (1977) 1.03
Agglutination of platelets by a serum factor in the presence of EDTA. J Clin Pathol (1969) 1.03
Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. J Hosp Infect (1996) 1.02
Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation. Cancer (1978) 1.02
Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukaemia: a multiparameter analysis of 300 cases. Br J Haematol (1980) 1.01
PM2.5 and PM10 concentrations from the Qalabotjha low-smoke fuels macro-scale experiment in South Africa. Environ Monit Assess (2001) 1.01
Myelosuppressive effect of colaspase (L-asparaginase) in initial treatment of acute lymphoblastic leukaemia. Br Med J (1974) 1.01
Intravenous immunoglobulin in HIV infection: evidence for the efficacy of treatment. Arch Dis Child (1989) 1.01